MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
RCUS
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

Arcus Biosciences (RCUS) Ownership - Who owns Arcus Biosciences?

Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Major
Address
3928 Point Eden Way
Phone
+1 510 694-6200
Employees
577
Web
https://www.arcusbio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.42B
P/E Ratio
N/A
Total Cash
822M
Projected Growth
N/A
Total Debt
113M
Revenue
236M
Risk (Beta)
1.44
Dividend Yield
N/A
Total Cash/Share
6.54
Total Debt/Equity
N/A
Revenue/Share
2.07 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
RCUS
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for RCUS
A.I. Advisor
published General Information

General Information

a company which offers pre-clinical drug discovery and development solutions

Industry Biotechnology

Profile
Details
Industry
Pharmaceuticals Major
Address
3928 Point Eden Way
Phone
+1 510 694-6200
Employees
577
Web
https://www.arcusbio.com